TBH Global Asset Management LLC Has $2.13 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

TBH Global Asset Management LLC boosted its position in HCA Healthcare, Inc. (NYSE:HCA) by 1.2% during the 4th quarter, Holdings Channel.com reports. The fund owned 7,081 shares of the company’s stock after buying an additional 83 shares during the quarter. TBH Global Asset Management LLC’s holdings in HCA Healthcare were worth $2,125,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in the business. Legacy Investment Solutions LLC bought a new stake in HCA Healthcare in the third quarter valued at about $39,000. Capital Performance Advisors LLP acquired a new stake in shares of HCA Healthcare in the 3rd quarter valued at approximately $41,000. Canoe Financial LP acquired a new position in HCA Healthcare during the third quarter valued at approximately $41,000. Northwest Investment Counselors LLC bought a new position in shares of HCA Healthcare during the third quarter worth $44,000. Finally, Activest Wealth Management grew its stake in HCA Healthcare by 1,250.0% in the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after acquiring an additional 125 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the transaction, the senior vice president now owns 15,412 shares in the company, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 1.70% of the company’s stock.

HCA Healthcare Trading Up 1.3 %

HCA stock opened at $320.82 on Thursday. The stock has a market cap of $81.26 billion, a price-to-earnings ratio of 14.60, a price-to-earnings-growth ratio of 1.08 and a beta of 1.64. The company has a fifty day moving average price of $313.30 and a two-hundred day moving average price of $351.29. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the prior year, the firm earned $5.90 earnings per share. Equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.90%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date is Monday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is currently 12.02%.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on HCA. StockNews.com cut HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. KeyCorp cut their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. Morgan Stanley dropped their price target on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 17th. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $380.00 target price on shares of HCA Healthcare in a research report on Tuesday, December 17th. Finally, Truist Financial decreased their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.